Your browser doesn't support javascript.
loading
Immunogenomic intertumor heterogeneity across primary and metastatic sites in a patient with lung adenocarcinoma.
Chen, Runzhe; Li, Jun; Fujimoto, Junya; Hong, Lingzhi; Hu, Xin; Quek, Kelly; Tang, Ming; Mitra, Akash; Behrens, Carmen; Chow, Chi-Wan; Jiang, Peixin; Little, Latasha D; Gumbs, Curtis; Song, Xingzhi; Zhang, Jianhua; Tan, Dongfeng; Heymach, John V; Wistuba, Ignacio; Futreal, P Andrew; Gibbons, Don L; Byers, Lauren A; Zhang, Jianjun; Reuben, Alexandre.
Afiliação
  • Chen R; Department of Thoracic/Head and Neck Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Li J; Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Fujimoto J; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou, 510060, Guangdong, China.
  • Hong L; Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Hu X; Regor Therapeutics, 2445 Main Street, Second Floor, MA, 02142, Cambridge, USA.
  • Quek K; Department of Translational Molecular Pathology, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Tang M; Department of Thoracic/Head and Neck Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Mitra A; Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Behrens C; Department of Thoracic/Head and Neck Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Chow CW; Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Jiang P; Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Little LD; Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Gumbs C; Department of Thoracic/Head and Neck Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Song X; Department of Translational Molecular Pathology, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Zhang J; Department of Thoracic/Head and Neck Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Tan D; Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Heymach JV; Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Wistuba I; Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Futreal PA; Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Gibbons DL; Department of Pathology, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Byers LA; Department of Thoracic/Head and Neck Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Zhang J; Department of Translational Molecular Pathology, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Reuben A; Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
J Exp Clin Cancer Res ; 41(1): 172, 2022 May 11.
Article em En | MEDLINE | ID: mdl-35546239

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans Idioma: En Revista: J Exp Clin Cancer Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans Idioma: En Revista: J Exp Clin Cancer Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido